Close menu
Brain & Behavior
Grants & Prizes
Home
Research
Illness
Addiction
Anxiety Disorders
Attention-Deficit Hyperactivity Disorder (ADHD)
Autism Spectrum Disorder (ASD)
Bipolar Disorder
Borderline Personality Disorder (BPD)
Depression
Eating Disorders
Mental Illness (General)
Obsessive-Compulsive Disorder (OCD)
Post-Traumatic Stress Disorder (PTSD)
Schizophrenia
Suicide Prevention
Other Brain-Related Illnesses
Category
Basic Research
New Technologies
Early Intervention/ Diagnostic Tools
Next Generation Therapies
Blog
Get Involved
Give
Donate Today
Memorial/Tribute (make donation)
Create Event or Memorial Page
Find a Memorial/Tribute Page
Stock/Securities Donations / IRA Charitable Rollovers
Other Giving Opportunities
Planned Giving
Research Partners
Donor Advised Funds
Workplace Giving
Team Up for Research!
Sponsorship Opportunities
Watch
Healthy Minds TV
Meet the Scientists Webinars
Videos
Connect
Ask the Expert
Join Us
Home
Grants
Grant FAQs
BBRF Young Investigator Grants
BBRF Independent Investigator Grants
BBRF Distinguished Investigator Grants
Prizes & Awards
Klerman & Freedman Prizes
Outstanding Achievement Prizes
Lieber Prize for Schizophrenia Research
Maltz Prize for Schizophrenia Research
Colvin Prize for Mood Disorders Research
Ruane Prize for Child and Adolescent Psychiatric Research
Goldman-Rakic Prize for Cognitive Neuroscience Research
The Pardes Humanitarian Prize
Productive Lives Awards
Blog
About Us
Who We Are
Our Impact
FAQs
Media Center
News
Press Releases
Opinion Pieces
In the News
Multimedia Library
Media Kit
Events & Webinars
Team Up for Research! Events
Healthy Minds TV
Contact
Email Signup
Open Menu

Menu

Are there new medications for schizophrenia in the works?

Go Back to the Questions

Q. Are there new medications for schizophrenia in the works?

Marc G. Caron, Ph.D.
Answer By: Marc G. Caron, Ph.D.
James B. Duke Professor of Cell Biology,
Duke University Medical Center

Marc G. Caron, Ph.D., of the Duke University Medical Center received the Lieber Prize for Outstanding Achievement in Schizophrenia Research from the Brain & Behavior Research Foundation in 2013. Learn more about the Outstanding Achievement Prizes at: http://bbrfoundation.org/outstanding-achievement-prizes.

Tags:
Schizophrenia
Ask an Expert

Related Articles

In Schizophrenia, Differences in the Brain’s Energy Pathways Suggest Possible New Treatment Target

READ

Posted: Thursday, February 18, 2021

In Schizophrenia, Differences in the Brain’s Energy Pathways Suggest Possible New Treatment Target

Read more
People With Schizophrenia Have Increased Risk of Dying From COVID-19, Research Reveals

READ

Posted: Thursday, February 4, 2021

People With Schizophrenia Have Increased Risk of Dying From COVID-19, Research Reveals

Read more
Combining the Antipsychotic Olanzapine with an Opioid-Receptor Blocker Significantly Limited Weight-Gain Risk in Schizophrenia Patients

READ

Posted: Thursday, January 28, 2021

Combining the Antipsychotic Olanzapine with an Opioid-Receptor Blocker Significantly Limited Weight-Gain Risk in Schizophrenia Patients

Read more
Study Reveals Adults With Mental Disorders Are At Significantly Higher Risk of COVID-19 and Have Poorer Outcomes

READ

Posted: Thursday, November 12, 2020

Study Reveals Adults With Mental Disorders Are At Significantly Higher Risk of COVID-19 and Have Poorer Outcomes

Read more